文献速递糖尿病

线粒体糖尿病:当代病例与精准医学方法

Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本文分析芝加哥大学单基因糖尿病注册中心15例线粒体糖尿病先证者,致病变异以m.3243A>G为主。队列中感音神经性耳聋占80%、肌无力占53%,受检者胰岛自身抗体均阴性。治疗包括胰岛素和磺脲类,部分使用双胍类;家族异质性检测显示显著家族内和家族间变异,强调尿样本异质性检测和基于线粒体病理生理的个体化管理。

要点

  • 线粒体糖尿病以m.3243A>G致病变异最常见,常伴耳聋和肌无力。
  • 胰岛自身抗体阴性有助于与自身免疫性糖尿病鉴别。
  • 尿样本异质性检测和个体化管理是精准医学策略的重要组成。

核心结论

  • 线粒体糖尿病是罕见单基因糖尿病,以m.3243A>G致病变异最常见,常伴感音神经性耳聋和肌无力。
  • 家族异质性检测显示显著家族内和家族间变异,支持尿样本异质性检测和基于线粒体病理生理的个体化管理。

研究设计与样本

  • 分析芝加哥大学单基因糖尿病注册中心15例线粒体糖尿病先证者,均有确诊致病变异,主要为m.3243A>G。
  • 其中3例先证者(3/15)用于详细病例研究和家系分析。

主要发现

  • 队列中感音神经性耳聋占80%,肌无力占53%。
  • 所有受检个体胰岛自身抗体均阴性。
  • 治疗方案包括胰岛素和磺脲类,部分报告使用双胍类。
  • 3例先证者报告线粒体鸡尾酒补充剂主观改善。
  • 家族异质性检测显示显著家族内和家族间变异。

临床怎么用

  • 对疑似线粒体糖尿病患者应关注感音神经性耳聋和肌无力等伴随表现。
  • 胰岛自身抗体阴性支持线粒体糖尿病而非自身免疫性糖尿病。
  • 可考虑尿样本异质性检测用于家系评估。
  • 治疗需个体化,使用双胍类时应考虑线粒体功能障碍相关安全性问题。

局限性

  • 队列样本量小,仅15例先证者,其中3例用于详细病例研究。
  • 部分治疗信息基于患者主观报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Maternally inherited diabetes and deafness (MIDD) syndrome is a rare form of monogenic diabetes most often caused by the pathogenic m.3243A > G mutation in the mitochondrial tRNALeu (UUR) gene, MT-TL1. Mutations causing MIDD are also associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. This paper analyzes the data of 15 probands with mitochondrial diabetes enrolled in the University of Chicago Monogenic Diabetes Registry, all of whom have confirmed pathogenic variants, primarily m.3243A > G. Three of these probands (3/15) were selected for detailed case studies and pedigree analysis. Among the total cohort, sensorineural hearing loss (80%) and muscle weakness (53%) were frequent comorbidities, and all tested individuals were negative for islet autoantibodies. Treatment regimens included insulin and sulfonylureas, with some reporting use of biguanides despite safety concerns related to mitochondrial dysfunction. Three probands noted subjective improvement with mitochondrial cocktail supplementation. Familial heteroplasmy testing revealed significant inter- and intrafamilial variability. This cohort represents 1 of the largest clinically characterized US populations with mitochondrial diabetes and underscores the importance of urine-based heteroplasmy testing and personalized management strategies informed by mitochondrial pathophysiology.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Oppenheimer KR, Himelhoch NT, McCullough ME, et al. Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach. J Clin Endocrinol Metab. 2026. PMID: 41472381. doi:10.1210/clinem/dgaf698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。